You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

The changing face of GIST: implications for pathologists

Hemmings, Chris1,2; Yip, Desmond3,4

Pathology:
doi: 10.1097/PAT.0000000000000047
Soft Tissue Pathology
Abstract

Summary: Gastrointestinal stromal tumour (GIST) is now recognised as the most common primary mesenchymal tumour of the gut. A number of different parameters have been identified to aid prediction of clinical behaviour, but prognostication for an individual remains difficult. The pathologist plays a crucial role in guiding management of these tumours, but is faced with a number of challenges in so doing. This review describes the variable pathological features that may be encountered, and examines some of the issues in the pathology reporting of GIST and attempts to provide some guidance in factors that should be addressed in a comprehensive pathology report.

Author Information

1St John of God Pathology Subiaco

2School of Surgery, University of Western Australia, Western Australia

3Department of Medical Oncology, The Canberra Hospital

4ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australia

Address for correspondence: Dr C. Hemmings, SJOG Pathology, Level 5, Bendat Family Comprehensive Cancer Centre, 12 Salvado Rd, Subiaco, WA 6008, Australia. E-mail: chris.hemmings@sjog.org.au

Received 5 September, 2013

Accepted 15 September, 2013

© 2014 Royal College of Pathologists of Australasia

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.